Skip to content

Envoy Medical COCH Warrants Issued With Term Loansrelated Party

Warrants Issued With Term Loansrelated Party at other companies

Jade Biosciences, Inc. Common Stock logo
Jade Biosciences, Inc. Common StockJBIO
$2.67M
Life360, Inc. logo
Life360, Inc.LIF
$0-100%
AMMO, Inc. logo
AMMO, Inc.POWW
$3.06M
ADMA Biologics logo
ADMA BiologicsADMA
$0
Applied Digital logo
Applied DigitalAPLD
$0+100%
Faraday Future Intelligent Electric Inc. Common Stock logo
Faraday Future Intelligent Electric Inc. Common StockFFAI
$491K-96.7%

Other financials

Income statement

See full
Revenue$39.0K-15.2%
Gross profit-$274.0K-52.2%
Operating income-$6.0M-16.7%
Net income-$4.4M+12.9%
EPS (diluted)-$0.08+72.4%

Balance sheet

See full
Cash & equivalents$25.3M+376%
Total debt$919.0K-2.8%
Total equity$10.2M+142%
Total assets$29.8M+187%

Cash flow

See full
Operating cash flow-$6.1M-62.7%
CapEx$172.0K
Free cash flow-$5.9M-28.5%

Valuation

See full
Market cap$61M+83.5%
P/S260.7×+111×

Profitability

See full
Gross margin-310.7%+31.6pp
Operating margin-9,881.2%+805pp
Net margin-9,875.6%+771pp
FCF margin-7,626.6%-652pp

Returns & leverage

See full
Return on equity328.7%
Debt / equity0.1×
Current ratio2.3×+1.2×

Where this comes from

Reported directly by Envoy Medical in its filing.

Tagged under the XBRL concept coch:WarrantsIssuedWithTermLoansrelatedParty.

The official record: Envoy Medical’s 10-Q, filed July 31, 2025, on SEC EDGAR. View the filing →

Ask your AI about Envoy Medical's warrants issued with term loansrelated party.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Envoy Medical's warrants issued with term loansrelated party?
Envoy Medical (COCH) reported warrants issued with term loansrelated party of $882K in Q2 2025.
What does warrants issued with term loansrelated party mean?
Represents the fair value of equity warrants granted to related parties as a component of debt financing arrangements. This metric highlights the additional cost of capital beyond stated interest rates and reflects the dilution risk associated with related-party debt.